MedPath

FCN-411

Generic Name
FCN-411

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/06/25
N/A
Completed
Wuhan Union Hospital, China
2020/09/17
Not Applicable
Completed
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
2020/03/27
N/A
Recruiting
Hunan Province Tumor Hospital
2018/01/03
Phase 2
UNKNOWN
Sichuan Cancer Hospital and Research Institute
2016/12/26
Phase 2
UNKNOWN
Shanghai Pulmonary Hospital, Shanghai, China
2016/08/08
Phase 3
UNKNOWN
Shanghai Pulmonary Hospital, Shanghai, China
2016/06/02
Phase 2
UNKNOWN
First People's Hospital of Hangzhou
2016/03/21
Phase 3
UNKNOWN
Sun Yat-sen University
2014/09/26
Phase 2
UNKNOWN
Wuhan Union Hospital, China
2012/12/10
N/A
UNKNOWN
Shanghai University of Traditional Chinese Medicine

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.